Corinne Pankovcin - 04 Jun 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Corinne Pankovcin
Issuer symbol
ADTX
Transactions as of
04 Jun 2021
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 16:05:45 UTC
Previous filing
25 May 2021
Next filing
13 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Award $0 +55,000 +48% $0.000000 169,220 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.